Search

everythinglearnresearchcommunity

for

Search:↓

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Standardized guidelines are needed to improve drug-loaded extracellular vesicle purification.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Hair test results can be misleading due to contamination, so they shouldn't be used alone to determine drug use.

The document explains various skin conditions in cats and how to diagnose and treat them.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

HIV patients with lower CD4 T cell counts often have more skin problems.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Polysaccharide-based niosomes improve drug delivery and show promise in cancer therapy but face challenges in scalability and stability.

PCOS treatment should be personalized, using birth control pills or metformin for symptoms, with lifestyle changes being essential.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Marine biomaterials show promise for drug delivery and wound healing.

Lipid-polymer hybrid nanoparticles show promise for skin treatments but need better formulation strategies.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

Different scalp imaging methods are important for studying hair and scalp health and require more volunteers for better evaluation.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.